NEW YORK (GenomeWeb) – Genome editing software company Desktop Genetics and Imperial College London's cancer epigenetics unit have received a £300,000 ($430,000) grant from Innovate UK, which they will use to develop software tools that selectively design CRISPR/Cas9 targets against cancer cell lines that are characterized at the epigenetic level.